Both HERC2 depletion and E3 inactivation sensitize cells to the G4-interacting compounds, telomestatin and pyridostatin. Overall, HERC2 is a master regulator of G4 suppression and affects the sensitivity of cells to G4 stabilizers.
INTRODUCTION
Specific guanine-rich DNA motifs containing four stretches of three or more consecutive guanines can fold into a secondary structure, known as the G-quadruplex (G4), via Hoogsteen base pairing stabilized by a monovalent cation [1, 2] . G4 structures were originally characterized in vitro using biophysical techniques, and recent high-throughput 5 sequencing techniques have identified more than 700,000 G4 structures genome-wide [3] .
Accumulating evidence has demonstrated its important functional roles in vivo that have recently attracted attention. G4 plays critical roles in telomere maintenance, replication initiation, and transcriptional initiation and termination. On the other hand, G4 can constitute obstacles for replication fork progression and transcription. Fork stalling and 10 transcription-associated DNA damage caused by G4s raise the potential to generate genomic instability and consequent development of cancer or disease [1, 2, 4] . Clinically, G4s may represent molecular targets to exploit genomic instability in cancers using G4-interacting compounds, such as telomestatin and pyridostatin [4] [5] [6] .
Several ATP-dependent DNA helicases have been shown to disassemble G4 [7] . 15 Among these, RecQ helicase family members, including BLM and WRN, that unwind noncanonical DNA structures in a 3' to 5' direction [8] , play major roles in G4 suppression [7, 9, 10] . Deficiencies in BLM and WRN cause Bloom and Werner syndromes, respectively; rare autosomal recessive disorders categorized in chromosome instability syndrome. Bloom syndrome is characterized by growth retardation, immunodeficiency, 20 hypersensitivity to sunlight, and predisposition to a wide spectrum of cancers [11] . Cells from Bloom syndrome patients show defects in DNA replication and homologous recombination, and exhibit a high frequency of sister chromatid exchanges [11] . In addition to G4s, the DNA substrates unwound by BLM include 3′-tailed duplexes, bubble structures, forked duplexes, DNA displacement loops, and double Holliday Junctions (dHJs) [8, 12, 13] . BLM is critical for repairing replication fork restoration by unwinding noncanonical DNA structures, preventing inappropriate recombination, and resetting stalled forks by fork regression [14, 15] . Werner syndrome is an adult-onset syndrome with a range of 5 features consistent with accelerated aging, including short stature, diabetes mellitus, osteoporosis, atherosclerosis, malignancies, and early death. [16] . Similar to BLM, WRN protein plays critical roles in DNA repair, replication, transcription, and telomere maintenance, and disrupts G4s, bubble structures, and dHJs at perturbed replication forks or DNA double-strand breaks [7, 8, [17] [18] [19] . 10
Both BLM and WRN physically interact with replication protein A (RPA) ([20, 21] , a heterotrimeric complex of RPA1 (RPA70), RPA2 (RPA32), and RPA3 (RPA14) that binds to single-stranded DNA (ssDNA) and prevents its spontaneous annealing. The interaction significantly stimulates helicases activity to unwind long duplex DNAs [20] [21] [22] , and accumulating evidence supports a function of RPA in G4 unfolding [23, 24] . In 15 addition to helicase activity, both BLM and WRN possess strand annealing activity, and rewind ssDNAs after unwinding double-stranded DNA (dsDNA) [25] . RPA increases the helicase activity, but inhibits their strand annealing activity [20] [21] [22] . Similarly, BLMmediated G4 unfolding is followed by G4 refolding [26] . Therefore, the helicases may require RPA to fulfill its function to suppress G4 in vivo. However, regulation of RPA-20 helicase interaction in vivo is not well understood.
HERC2 is a large HECT and RCC-like domain-containing protein comprising 4834 amino acids. Mutations in the HERC2 gene have been linked to a developmental 6 delay [27, 28] , and mice with homozygous truncation of the gene are not viable [29] . While HERC2 performs a range of functions with various interacting proteins, one of its major roles is the regulation of DNA replication and damage response. HERC2 controls nucleotide excision repair [30] and homologous recombination [31] , fine-tunes ubiquitinmediated DNA damage response via the deubiquitinating enzyme, USP16 [32] , and 5 modulates p53 activity [33] . HERC2 interacts with BRCA1 and is capable of suppressing G2-M checkpoint activity by degrading BRCA1 in BARD1-depleted cells [34] . HERC2 is a component of the replication fork complex [35] and suppresses the Chk1-directed checkpoint by degrading the deubiquitinating enzyme, USP20 [36, 37] . Hence, while HERC2 likely plays a pivotal role in DNA replication and the damage response, its function 10 remains unclear. Here, we demonstrate a previously unrecognized function of HERC2 that involves novel binding partners BLM, WRN, and RPA. HERC2 suppresses G4 via BLM and WRN, in a process reliant in the ubiquitin ligase activity of HERC2. Inhibition of HERC2 function sensitizes cells to G4-interacting compounds. Interestingly, HERC2 expression is frequently reduced in many types of cancers; therefore, these results highlight 15 the critical role of HERC2 on chromosomal stability in cancers, as well as its importance as an indicator for the efficiency of G4 stabilizers in cancer treatments.
RESULTS

HERC2 interacts with BLM, WRN, and RPA complexes in S-phase nuclear extracts 20
To investigate the function of HERC2, we raised rabbit polyclonal antibody specific to a C-terminal fragment of HERC2 and analyzed the HERC2 immunocomplex isolated from HeLa and HCT116 cells using mass spectrometry. In addition to the proteins previously reported to interact with HERC2 ( Figure S1A ), mass spectrometry analyses identified all subunits of the BTR complex consisting of BLM, topoisomerase IIIa (TOP3A), RMI1 (also known as BLAP75), and RMI2 (BLAP18), that function as a dissolvasome to dissolve dHJs and other secondary DNA structures [38] [39] [40] (Figure 1A ). The analyses also identified WRN, all subunits of the RPA complex, and another BLM-interacting protein, 5 BRCA1/BARD1 [41] . HERC2 immunoprecipitation followed by immunoblotting verified these interactions ( Figure 1B ).
HERC2 is a nuclear-cytoplasmic shuttle protein that localizes in both fractions and is abundantly expressed during all phases of the cell cycle [30, 34] . To uncover specific cellular conditions in which HERC2 functions with BLM, WRN, and RPA, we analyzed 10 their interaction in separated cellular fractions and in each phase of the cell cycle.
Fractionation analysis revealed that HERC2 interacts with these complexes mostly in soluble nuclear extracts but not in cytosolic and chromatin fractions ( Figure 1C ).
Fractionation efficiency was demonstrated with tubulin (cytosol), PARP1 (nuclear extract), and histone H3 (chromatin). We next synchronized HeLa cells. To minimize the effects 15 according to cellular response to thymidine-induced replication stress, cells were treated with a thymidine-nocodazole block and released into the cell cycle, then harvested at mitosis (0 h), G1 (6 h), and S (14 h) phases. HERC2 immunoprecipitation from nuclear extracts followed by immunoblotting demonstrated that HERC2 interacts with the BTR, WRN, RPA, and BRCA1/BARD1 complexes mainly during S-phase ( Figures 1D and S1B) . 20
Both BLM and WRN are capable of directly interacting with RPA in vitro [20] [21] [22] , suggesting that the HERC2-RPA interaction is mediated by BLM and/or WRN, or vice versa. To clarify the configuration of the HERC2 complex, we inhibited subunits of the 8 complex using siRNA and performed HERC2 immunoprecipitation followed by immunoblotting. Depletion of BLM clearly suppressed coprecipitation of TOP3A and RMI2, whereas depletion of TOP3A only inhibited coprecipitation of RMI2 but not BLM ( Figure 1E ), indicating that BLM bridges the interaction between the HERC2 and BTR complex. In contrast, interaction of HERC2 with RPA1 and RPA2 was not inhibited by the 5 depletion of either BLM or TOP3A ( Figures 1E and S1C) . The HERC2-RPA interaction was not inhibited by depletion of WRN ( Figure 1F ), indicating that RPA interacts with HERC2 independent of BLM and WRN. We next investigated depletion of RPA1 and Phosphorylation of RPA2 at Ser 4/8 and Ser33, which are induced by DNA-dependent protein kinase and ATR [44] , was increased at 8 or 16 h after the stress when the BLM-RPA interaction was reduced, indicating that RPA2 interacted with BLM and affected by HERC2 is in its unphosphorylated form. Together, these findings indicate that HERC2 mediates BLM-RPA interaction in unstressed cells.
To further confirm the effects of HERC2 on BLM-RPA complex formation, we performed gel filtration analyses using HeLa-shHERC2 cells ( Figure 2C ). Without HERC2-depletion, RPA1 and RPA2 coeluted with BLM in high-molecular-mass fractions 5 at fraction 8 to 13 where HERC2 also coeluted, consistent with the complex formation of these proteins. Notably, the RPA1 and RPA2 fractions shifted dramatically to lower molecular weights with elution peaks around 158 to 440 kDa (fractions 15 and 16) following Dox induction, whereas BLM remained in the high-molecular-mass fractions, supporting BLM-RPA dissociation. These results indicate that RPA exists in high-10 molecular-mass complex(es) with BLM in a HERC2-dependent manner. Gel filtration experiments showed that distributions of fractions for BLM and RPAs following MMC treatment were analogous to that induced by HERC2 depletion (Figure S2D ), supporting a role for HERC2 in BLM-RPA interaction in unstressed cells.
The HERC2-dependent interaction of BLM and RPA prompted us to test whether 15 HERC2 was also involved in WRN-RPA interaction in the same way. As shown in Figure   2D , HERC2 was found to mediate WRN-RPA interaction in unstressed cells, and this interaction was reduced after a 16-h incubation with HU. Together these results suggest that HERC2 does not simply interact with BLM-RPA and WRN-RPA complexes, but is also required for their formation. 20
HERC2 is epistatic to BLM and WRN in G4 suppressing function
RPA plays a supportive role in the helicase reaction of BLM and WRN in vitro [20] [21] [22] ; therefore, the absence of RPA in the BLM and WRN complexes by HERC2 depletion may affect the biological function of the helicases. To clarify this, we investigated whether HERC2 depletion resulted in G4 accumulation, a common phenotype shared by BLM and 5 WRN dysfunction [7, 9, 10] . G4 was analyzed by immunostaining using a G4-specific antibody BG4 [45] . The antibody detected G4 as nuclear foci that were enhanced by a BLM inhibitor or G4 stabilizers (Figures S3A and S3B). HeLa-shHERC2 cells were then induced or not with Dox and immunostained for G4 ( Figure 3A ). Without replication stress, G4 accumulation was remarkably enhanced by HERC2 depletion, indicating that HERC2 10 represses constitutive G4 accumulation. Brief exposure to HU reduced G4, consistent with previous observations that replication arrest via brief exposure to aphidicolin reduced G4 [45] . HERC2-depleted cells briefly exposed to HU still exhibited significantly higher rates of G4, reflecting an accumulation at the basal level. Similar results were also observed in HERC2-depleted U2OS cells ( Figure S3C ). 15
The similarities in phenotype shared by HERC2 depletion with dysfunction of BLM and WRN prompted us to examine whether the observed effects of HERC2 depletion on G4 were mediated by BLM and/or WRN dysfunction. To examine this, we analyzed the epistatic effects of HERC2 and BLM/WRN depletion. HeLa-shHERC2 cells were transfected with control siRNA or BLM-specific siRNA then induced or not with Dox and 20 immunostained for G4 ( Figure 3B ). The efficient depletion of both proteins was confirmed by immunoblotting. To our surprise, the level of G4 accumulation in HERC2-depleted cells was much higher than in BLM-depleted cells. In addition, BLM depletion in HERC2-depleted cells did not change the level of G4 accumulation compared with that of cells with HERC2-single depletion, suggesting that HERC2 is epistatic to BLM in the suppression of G4. An epistatic relationship was also observed between HERC2 and WRN ( Figure 3C ).
Finally, we performed triple knockdown of HERC2, BLM, and WRN and analyzed their epistatic relationship during G4 regulation ( Figure 3D ). The efficient 5 depletion of all three proteins was confirmed by immunoblotting. G4 accumulation in cells with a single BLM or WRN depletion was similar. On the other hand, double depletions of BLM and WRN caused significantly higher levels of G4 than a single depletion, suggesting that BLM and WRN function in different pathways or influence different subsets of G4.
Interestingly, G4 accumulation in BLM/WRN double-depleted cells was approximately 10
equal to that of HERC2-depleted cells, and a BLM/WRN double depletion did not further increase G4 in HERC2-depleted cells. Together, these results indicate that HERC2 suppresses G4 in a manner epistatic to the additive effects of BLM and WRN, the two major RecQ helicases involved in G4 unwinding.
15
HERC2 does not anchor to RPA-coated ssDNA
In addition to its role to prevent the secondary structure of DNA, ssDNA-binding RPA plays a critical role as a scaffold for DNA metabolism proteins such as ATR-ATRIP in the stalled replication fork in response to replication stress or DNA damage [46] . Therefore, one obvious possibility for the role of HERC2, which mediates interaction of BLM, WRN, 20 and RPA, is recruitment of the helicases to the RPA scaffold. However, this was contradicted by the observation that HERC2 facilitated the interaction in unstressed conditions that reduced with ATR-mediated phosphorylation of RPA in response to replication stresses ( Figures 2B and S2C) . To clarify this, we first examined the intracellular localization of HERC2. HERC2 localizes both in the nucleus and the cytoplasm [30, 34] and colocalizes with replication fork complex proteins including PCNA in the nucleus [35] . Costaining of HERC2 and RPA2 showed that HERC2 colocalizes with RPA2 in dispersed nuclear foci in normal proliferating cells ( Figure 4A, upper panels) . 5
This colocalization disappeared as RPA2 became discrete nuclear foci after a 16-h incubation with HU (lower panels), suggesting that HERC2 does not interact with RPAcoated ssDNA at stalled replication forks. The specificity of the HERC2 antibody used for immunostaining was confirmed by depletion of HERC2 ( Figure S4 ).
To further clarify the configuration of the HERC2-RPA-ssDNA interaction, we 10 examined whether the HERC2-RPA complex was capable of interacting with ssDNA in vitro. HERC2 complexes were immunoprecipitated from HeLa cell lysates using anti-HERC2 antibody-coated dynabeads, and incubated with biotin-labeled ssDNA ( Figure 4B) .
Notably, addition of ssDNA removed RPA from HERC2 in dose-dependent manner. We then subjected the elution to StrepTactin-pulldown and confirmed that RPA was transferred 15 from HERC2 to ssDNA. The transfer was ssDNA specific, but not specific for dsDNA ( Figure 4C) , and also required a certain length (~ 30 nt) of ssDNA ( Figure 4D ). Thus, the results indicate that HERC2 is not scaffold to mediate protein interactions on RPA-coated ssDNA. Instead, HERC2 may facilitate the delivery of RPA to ssDNA.
20
Deletion of the catalytic site of HERC2 causes RPA accumulation in BLM and WRN complexes and increases G4
HERC2 comprises Cys4762, a conserved catalytic ubiquitin-binding site of the HECT domain in most C-termini that is essential for the enzyme activity [34] . To uncover whether the E3 ubiquitin ligase activity affects BLM-RPA complex formation and is involved in 5 the observed phenotypes of HERC2 dysfunction, we disrupted the C-terminal end of the HERC2 gene using CRISPR/Cas9 nuclease-mediated genome editing and established a HCT116 cell line with a homozygous insertion mutation that generates a premature stop codon at Glu4758 and deletes Cys4762 (hereafter referred to as HERC2 ΔE3/ΔE3 , Figure 5A ).
The steady state level of mutated HERC2 was the same level as the wild type (WT), as 10 determined by an antibody to the epitope at amino acids 1781-1974 of HERC2 ( Figure   5B ). On the contrary, an antibody to the epitope at amino acids 4784-4834 failed to detect the mutant HERC2, indicating successful deletion of the HERC2 C-terminus.
Using cells, we first tested whether mutant HERC2 retained the ability to interact with BLM, WRN, and RPA complexes. Due to a lack of an antibody for 15 immunoprecipitation of HERC2 ΔE3/ΔE3 , we performed immunoprecipitation using antibodies to BLM, WRN, RPA1, and RPA2, followed by immunoblotting with a HERC2
antibody to the epitope at amino acids 1781-1974. The results showed that HERC2 
HERC2 dysfunctions sensitize cells to G4-stabilizing compounds
It was reported that depletion of FANCJ, a 5′ to 3′ DNA helicase that also unfolds G4, 20 sensitizes cells to G4-interacting compounds [6] . Thus, accumulation of G4 by HERC2 dysfunction prompted us to test whether it affected the sensitivity of cells to G4-interacting compounds. HeLa-shHERC2 cells were induced or not with Dox, exposed to a range of doses of pyridostatin and telomestatin, the G4-interacting ligands that stabilize G4, and allowed to form colonies. Remarkably, Dox-induced depletion of HERC2 sensitized the cells to both pyridostatin and telomestatin ( Figure 6A ). Whereas accumulation of G4 may be obstacle for DNA replication, cell growth of the Dox-induced HERC2-depleted cells was only slightly suppressed compared with HERC2-expressing cells (Figure S6A) , 5
suggesting that cells were able to overcome the obstacle. In contrast to the G4 stabilizers, HERC2 depletion did not dramatically affect the sensitivity of the cells to replication stress induced by MMC, CPT, and HU ( Figure 6A ).
We also tested the effect of inhibiting HERC2 E3 activity on the sensitivity of cells to agents using HERC2 ΔE3/ΔE3 cells. Similar to HERC2-depleted HeLa cells, HCT116 10
HERC2
ΔE3/ΔE3 cells exhibited significantly higher sensitivity to the G4-stabilizers than WT cells ( Figure 6B ). The effect of HERC2 inhibition was especially robust for telomestatin- show increased sensitivity to the replication stresses except for that induced by MMC ( Figure 6B ). Together, these results indicate that HERC2 dysfunction abrogates G4 processing and sensitizes cells to G4 stabilizers.
HERC2 expression in cancer 20
To investigate the clinical significance of HERC2 in human cancer, we analyzed TCGA Many previously characterized RPA-interacting proteins were recruited to RPAcoated ssDNA in response to replication stress or DNA damage [46] . Therefore, we hypothesized that HERC2 may act as a scaffold that recruits BLM and WRN to the RPA-coated ssDNA. However, our results demonstrated that this was not the case because (i) HERC2 bridges the helicases and RPA principally in unstressed cells and the interaction was reduced in response to replication stress, (ii) RPA2 associated with the helicases through HERC2 is in its unphosphorylated form, (iii) HERC2 does not colocalize with replication stress-induced RPA2 foci, and (iv) ssDNA competes with RPA binding to 5 HERC2 in vitro. Consistent with this observation, the stalled replication fork-associated proteomes did not identify HERC2 [47] . One possible scenario is that HERC2 acts on the normal replication machinery to resolve G4 structures by delivering RPA or the helicases, or both. The secondary structures of G-rich DNA occasionally impede the replication machinery, and BLM and WRN have been associated with the machinery and contribute 10 in the removal of intramolecular G4 structures that form after dsDNA unwinding by the replicative helicase [48] [49] [50] . RPA is also capable of unfolding G4 structures in the absence of ATP and prevents G4 in the lagging strand during telomeric replication [23, 24] . HERC2 may supply RPA to the DNA locus neighboring the helicases where RPA stimulates the helicase activity by binding them directly and inhibiting the rewinding activity of the 15 helicases, or assisting the helicases by preventing reannealing of the unfolded DNA ( Figure   S8B ). Although a biochemical approach using purified proteins is required to elucidate the precise function of HERC2 in the process, the extremely large molecular size of HERC2 limits this at present.
It is interesting that the abundant fraction of the RPA proteins in the soluble 20 nuclear fraction forms the complex with HERC2, and prolonged replication stress results in dissociation of RPA from the complex (Figures 2C and S3D) . Given that the majority of RPA is present in the nucleosol and only one-third of RPA is associated with chromatin
[51], RPA complexed with HERC2 in the soluble nuclear fraction could function as a backup system for situations with high demands for RPA, such as repair synthesis. A mechanism to save abundant cellular RPA via ATR has been reported to be critical to prevent global exhaustion of RPA that leads to a replication catastrophe in response to replication stress [52] . HERC2 may store such an RPA pool for immediate use at loci that 5 demand BLM and WRN.
Whereas the essential role of E3 activity of HERC2 on G4 suppression in vivo was clear from the observation in the E3 inactivated HERC2 ΔE3/ΔE3 cells, its molecular bases are unclear at present. As a possible event involved in the mechanism, we found that RPA accumulated in BLM or WRN complexes in the HERC2 ΔE3/ΔE3 cells. It is possible 10 that the E3 activity of HERC2 could be required for proper dissociation of RPA from the HERC2-helicase complexes and consequent delivery of RPA to ssDNA in vivo. Finetuning of the affinity between the helicases and RPA could be crucial in a highly repetitive DNA unfolding process, the action shared by BLM [53, 54] and other RecQ helicases [55] .
It is likely that G4 accumulation itself does not harm cell viability. HERC2-15
depleted cells with constitutively accumulated G4 grow almost normally ( Figure S6A ). Furthermore, significant G4 accumulation can be detected in stomach or liver cancer tissues [56] , suggesting that such cancer cells grow with increased G4. However, we show that both HERC2-depleted cells and HERC2 E3-inactivated cells were hypersensitive to the G4-stabilizers, pyridostatin and telomestatin, likely due to baseline accumulation of G4, 20 which increases the opportunity for G4 stabilizers to bind. Telomestatin is a potent telomerase inhibitor and causes telomere shortening [57] . However, it also induces DNA damage in telomeres and other regions. Telomestatin impairs the proliferation of FANCJ-20 depleted cells in telomerase independent manner [6] . Importantly, G4-stabilizers are particularly toxic to BRCA-defective cells acquiring PARP inhibitor resistance [5] , indicating pharmacological application exploiting G4 stabilization as a new therapeutic approach for cancers resistant to existing drugs. Although the mechanism inducing the toxicity may not be identical, HERC2 deficiency could be applicable to cancer therapy with 5 G4 stabilizers, because HERC2 expression is frequently reduced in many types of cancers.
MATERIALS AND METHODS
Cell lines, Culture Conditions and Synchronization
HeLa, HCT116, U2OS and HEK293T cells were obtained from ATCC and cultured as 10 described previously [58] . All cells were routinely monitored for mycoplasma. Cells stably expressing HERC2-or BRCA1-specific shRNA in a doxycycline-inducible manner were established by the lentiviral infection of CS-RfA-ETBsd comprising targeting sequences followed by selection with blasticidin as described [58] . The cells were treated with 1 µg/ml Dox for 48 h and subjected to individual experiments. For CRISPR/Cas9-mediated genetic 15 engineering HCT116 cells were transfected with LentiCRISPRv2 plasmid comprising a human codon-optimized Cas9 (hSpCas9) nuclease along with a single guide RNA (sgRNA, targeting sequence: AACAGGTGTAGGACTCAGGG). Cells were selected with puromycin (1 μg/ml) and single colonies were picked up and further cultured. Mutation of HERC2 gene was confirmed by genetic sequencing and immunoblot. Cell cycle 20 synchronization with thymidine-nocodazole block and its monitoring by flow cytometry were described previously (59).
Chemical agents
Chemical agents used were HU (Sigma-Aldrich), MMC (Sigma-Aldrich), CPT (irinotecan hydrochloride, Sigma-Aldrich), MG132 (Calbiochem), Telomestatin (Cosmo Bio Co. LTD), Pyridostatin (Sigma-Aldrich), and BLM inhibitor (ML-216 Cayman Chemical).
5
Fractionation of cellular extract
To prepare cytosolic, nuclear, and solubilized chromatin fractions, 3 × .5], 0.5% Nonidet P-40, 150 mM NaCl, 50 mM NaF, 1 mM dithiothreitol, 1 mM NaVO3, 1 mM PMSF, 2 µg/ml aprotinin, 2 µg/ml leupeptin, 10 µg/ml trypsin inhibitor, and 150 µg/ml benzamidine) supplemented with 125 U/ml Benzonase nuclease (Novagen) and 2 mM Mg at 4°C for 120 min, and the reaction was stopped with 5 mM EDTA. The extract was centrifuged to isolate the chromatin-bound 20 proteins in the soluble fraction, filtered through a 0.45-µm-pore-size filter, and used as solubilized chromatin fractions.
Antibodies
Rabbit polyclonal antibody to C-terminal HERC2 was generated against recombinant HERC2 protein (residues 4389-4834) fused to hexa-histidine and purified by protein G agarose chromatography. The commercially available antibodies used in the study were rabbit polyclonal antibodies against HERC2 (epitope 4784-4834, Bethyl Laboratories, 
15
Immunoprecipitation and immunoblotting
Unless otherwise indicated cell lysates were prepared with the 0.5% NP-40 buffer followed by Immunoprecipitation and immunoblotting as described previously [60] . 
Gel Filtration Analysis (Size Exclusion Chromatography)
Nuclear extracts (2 mg/0.5 ml) were applied to Superose 6 10/300 GL column (GE 5 Healthcare) and fractionated using an AKTA Purifier (GE Healthcare) liquid chromatography system with a flow rate of 0.4 ml/min in buffer consisting of 50 mM TrisHCl (pH 7.4), 1 mM EDTA, 0.1% CHAPS, 1 mM DTT, and 150 mM NaCl. 500 µl fractions were collected after 5 ml and analyzed by western blot analysis. The approximate molecular weight was estimated with Gel Filtration Calibration kit (GE Healthcare). 10
Immunofluorescence microscopy HERC2/RPA2 staining was performed using cold methanol and acetone as described previously [35] . For staining of G4, mixed methanol:acetic acid (3:1) solution was used as described elsewhere [45] followed by 0.5% Triton X-100 in PBS with 200 µg/ml RNase 15
A. Subsequently, the cells were washed, blocked with 3% goat serum and 0.1% Triton X-100, and labeled with primary and fluorescence-labeled secondary antibodies. The slides were mounted with ProLong Gold Antifade Mountant with DAPI (Invitrogen) and examined with a confocal laser-scanning microscope (LSM 510, Carl Zeiss, Germany). G4 nuclear foci were mechanically counted using the Cellomics Image Analyzer (Thermo 20 Fisher).
Clonogenic survival assay
Cells were seeded at a concentration of 500 cells/well in 6-well plates and after 6 h different concentrations of agents were added. After 24 h of incubation, the cells were washed and further cultured in fresh medium without the chemicals for 14 days. The cells were then fixed and stained with crystal violet. The colonies were scanned and counted using an ImageQuant LAS-4000 instrument (GE Healthcare). 5 HCT116 cells (B) were exposed to indicated doses of the chemical agents for 24 h and analyzed for clonogenic survival after two weeks. The data are shown with the nonlinear 15 regression fit curves of one phase decay (GraphPad Prism). Average ± SEM, normalized to cells without agents were derived from triplicate experiments. Statistical significances were calculated using two-way ANOVA. * P < 0.0001.
TCGA data analysis
